1 completed, 1 terminated, 1 withdrawn. 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Not applicable | 1 | Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Decreased Immunologic Activity: new trials by email Literature Review of Decreased Immunologic Activity trials Research Report on Decreased Immunologic Activity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS) Assigned Interventions - Disorder Related to Lung Transplantation, Chronic Rejection of Lung Transplant | Phase 2 | Withdrawn | University of Maryland, Baltimore | 2020-06-30 | 2023-05-06 | |
| Combined Apheresis for ABO-incompatible Transplantation - a Pilot Study Combined apheresis - Decreased Immunologic Activity, Antibody-mediated Rejection | Not applicable | Terminated | Medical University of Vienna | 4 | 2014-10-01 | 2022-08-24 |
| Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients Liposomal aerosol cyclosporine, standard immune suppression, oral - Disorder Related to Lung Transplantation, Bronchiolitis Obliterans | Phase 1 / Phase 2 | Completed | University of Maryland, Baltimore | 21 | 2012-07-01 | 2023-06-01 |
Bronchiolitis Obliterans Syndrome (2) · Bronchiolitis Obliterans (1)
Bronchial Diseases (2) · Bronchiolitis (2) · Bronchitis (2) · Graft vs Host Disease (2) · Immune System Diseases (2) · Lung Diseases (2) · Lung Diseases, Obstructive (2) · Organizing Pneumonia (2) · Respiratory Tract Diseases (2) · Bronchiolitis Obliterans (1)
Sirolimus (2) · Tacrolimus (2) · Cyclosporine (1) · Mycophenolic Acid (1) · Prednisone (1)
University of Maryland, Baltimore (2) · Medical University of Vienna (1)
Austria (1) · United States (1)